Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GSK invests $300m in 23andMe under drug development deal

pharmaceutical-technologyJuly 27, 2018

Tag: GSK , Drug development

PharmaSources Customer Service